净收入 更改
3i Infrastructure GBP 258M 94M 2025-12
AstraZeneca USD 2.33B 207M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Hikma Pharmaceutical USD 164M 45M 2025-12